SFX by Ex Libris Inc.

Title:	Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation
Source:	Nature [0028-0836] Lechtenberg, B C yr:2016

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Bueno, Amy N. "Dynamics of an Active-Site Flap Contributes to Catalysis in a JAMM Family Metallo Deubiquitinase." Biochemistry 54.39 (2015): 6038-6051.
description	2.	Luo, Chong T. "Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity." Nature 529.7587 (2016): 532-6.
description	3.	UENO, Y. "ACTIVATION OF NITROSO GROUP WITH THIOLS - A NEW TRANSFORMATION OF PRIMARY AMINES TO ORGANIC SULFIDES OR THIOLS." Tetrahedron letters 25.25 (1984): 2675-2678.
description	4.	Lee, J. "Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy." The journal of cell biology 189.4 (2010): 671-679.
description	5.	Lee, J. "HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy." EMBO Journal 29.5 (2010): 969-980.
description	6.	Gavrilov, Y. "Nonspecific yet decisive: Ubiquitination can affect the native-state dynamics of the modified protein." Protein science 24.10 (2015): 1580-92.
description	7.	Wertz, I. "DUBs, the regulation of cell identity and disease." Biochemical journal 465.1 (2015): 1-26.
description	8.	Kirk, A D. "CD28 negative T cells: is their loss our gain?" American journal of transplantation 14.11 (2014): 2460-6.
description	9.	Franklin, Ruth A. "The Cellular and Molecular Origin of Tumor-Associated Macrophages." Science 344.6186 (2014): 921-925.
description	10.	Garraway, Levi A. "Precision Oncology: An Overview." Journal of clinical oncology 31.15 (2013): 1803-1805.
description	11.	Ramsey, Chenere P. "IDENTIFICATION AND CHARACTERIZATION OF A NOVEL ENDOGENOUS MURINE PARKIN MUTATION." Journal of neurochemistry 113.2 (2010): 402-417.
description	12.	Simon, J. "Roles of the EZH2 histone methyltransferase in cancer epigenetics." Mutation research 647.1-2 (2008): 21-29.
description	13.	Moretta, A. "Human NK cells : from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias." Immunological reviews iews0105-2896August.1 (2008): 58-69.
description	14.	Rubinsztein, David C C. "Alpha-Synuclein is degraded by both autophagy and the proteasome." The Journal of biological chemistry 278.27 (2003): 25009-13.
description	15.	Deaton, David N N. "Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite." Bioorganic & medicinal chemistry letters 18.2 (2008): 1681-7.
description	16.	Kirby, P. "Association between early-onset Parkinson's disease and mutations in the parkin gene." The New England journal of medicine 342.21 (2000): 1560-7.
description	17.	Neuspiel M, M. "Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers." Current biology 18.2 (2008): 102-8.
description	18.	Shimizu, N. "Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism." Nature 392.6676 (1998): 605-608.
description	19.	Mendelsohn, J. "Personalizing Oncology: Perspectives and Prospects." Journal of clinical oncology 31.15 (2013): 1904-1911.
description	20.	Garraway, Levi A. "Genomics-Driven Oncology: Framework for an Emerging Paradigm." Journal of clinical oncology 31.15 (2013): 1806-14.